A webcast of the on-demand presentation will be available beginning Monday, January 10, 2022 on the Company's website at www.anavex.com.
Yup, caught my attention right off. If that does present good/sufficient technology/trial detail/results then we have a winner, IMO. It is not complicated, if it is not adequate then we have a problem. Fingers crossed for solid work by AVXL team.
There are a few such points I considered different and took them as a good sign. I would not want to be betting against an AVXL win.
georgejjl Wednesday, 01/05/22 12:08:09 PM Re: None 0 Post # 342718 of 343111 Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex, will present at the H.C. Wainwright Virtual BioConnect 2022 Conference being held January 10-13, 2022.
A webcast of the on-demand presentation will be available beginning Monday, January 10, 2022 on the Company's website at www.anavex.com.